Medications

Update shows relatlimab + nivolumab slows advanced melanoma

For patients with previously untreated metastatic or unresectable melanoma, the combination of relatlimab + nivolumab continues to demonstrate a progression-free survival (PFS) benefit over nivolumab alone, according to updated ...

Oncology & Cancer

Changing the standard of care for stage III melanoma surgery

For years, surgery for patients with stage III melanoma—melanoma that has spread to the lymph nodes—involved removing those lymph nodes along with the primary tumor. Known as completion lymph node dissection (CLND), the ...

page 1 from 8